Content area

|
|

Begrænset evidens for monitorering og behandling af fosfatmangel hos kritisk syge patienter

Forfatter(e)
Christine Federspiel1, Theis S. Itenov1, Katrin Thormar2 & Morten H. Bestle1 1) Anæstesiologisk Afdeling, Nordsjællands Hospital 2) Anæstesiologisk Afdeling, Bispebjerg Hospital Ugeskr Læger 2015;177:V07150610
Reference: 
Ugeskr Læger 2015;177:V07150610
Blad nummer: 
Sidetal: 
2-6
Limited evidence for monitoring and treatment of hypophosphataemia in critically ill patients
Hypophosphataemia is a potentially hazardous metabolic disturbance which is common in critically ill patients. The condition is reported to be associated with severe complications and increased mortality. It is unknown, whether hypophosphataemia has a causal effect or reflects the severity of illness. There are no randomized clinical trials to support treatment of hypophosphataemia with intravenous phosphate substitution, which has resulted in large variations in monitoring and treatment of hypophosphataemia in the intensive care unit.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Mats Lindberg | 11/05
3 kommentarer
af Claus Hancke | 11/05
1 Kommentar
af Mette Haase Moen | 10/05
1 Kommentar
af Lars Stig Andersen | 08/05
2 kommentarer
af Jacob Peter Philipsen | 03/05
2 kommentarer
af Nils Thorm Milman | 03/05
1 Kommentar
af Thora Gudrunardottir | 01/05
1 Kommentar